Cellectis SA (CLLS)
2.975
+0.04
(+1.54%)
USD |
NASDAQ |
Jun 09, 13:10
Cellectis Total Assets (Quarterly) : 289.19M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 266.40M |
| Akari Therapeutics Plc | 33.89M |
| Amarin Corp. Plc | 645.76M |
| Grifols SA | 23.13B |
| Autolus Therapeutics Plc | 527.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 229.27M |
| Shareholders Equity (Quarterly) | 59.92M |
| Debt to Equity Ratio | 1.812 |
| Current Ratio | 1.521 |
| Net Debt Paydown Yield | 0.07% |